Literature DB >> 15576381

Combinatorial exploration of the catalytic site of a drug-resistant dihydrofolate reductase: creating alternative functional configurations.

Andreea R Schmitzer1, François Lépine, Joelle N Pelletier.   

Abstract

We have applied a global approach to enzyme active site exploration, where multiple mutations were introduced combinatorially at the active site of Type II R67 dihydrofolate reductase (R67 DHFR), creating numerous new active site environments within a constant framework. By this approach, we combinatorially modified all 16 principal amino acids that constitute the active site of this enzyme. This approach is fundamentally different from active site point mutation in that the native active site context is no longer accounted for. Among the 1536 combinatorially mutated active site variants of R67 DHFR we created, we selected and kinetically characterized three variants with highly altered active site compositions. We determined that they are of high fitness, as defined by a complex function consisting jointly of catalytic activity and resistance to trimethoprim. The k(cat) and K(M) values were similar to those for the native enzyme. The favourable Delta(DeltaG) values obtained (ranging from -0.72 to -1.08 kcal/mol) suggest that, despite their complex mutational pattern, no fundamental change in the catalytic mechanism has occurred. We illustrate that combinatorial active site mutagenesis can allow for the creation of compensatory mutations that could not be predicted and thus provides a route for more extensive exploration of functional sequence space than is allowed by point mutation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15576381     DOI: 10.1093/protein/gzh090

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  9 in total

1.  Tuning of the H-transfer coordinate in primitive versus well-evolved enzymes.

Authors:  Atsushi Yahashiri; Elizabeth E Howell; Amnon Kohen
Journal:  Chemphyschem       Date:  2008-05-16       Impact factor: 3.102

2.  Asymmetric mutations in the tetrameric R67 dihydrofolate reductase reveal high tolerance to active-site substitutions.

Authors:  Maximilian C C J C Ebert; Krista L Morley; Jordan P Volpato; Andreea R Schmitzer; Joelle N Pelletier
Journal:  Protein Sci       Date:  2014-12-26       Impact factor: 6.725

3.  GREBP, a cGMP-response element-binding protein repressing the transcription of natriuretic peptide receptor 1 (NPR1/GCA).

Authors:  Guy Martel; Pavel Hamet; Johanne Tremblay
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

4.  Novel crystallization conditions for tandem variant R67 DHFR yield a wild-type crystal structure.

Authors:  Brahm J Yachnin; Damien Y Colin; Jordan P Volpato; Maximilian Ebert; Joelle N Pelletier; Albert M Berghuis
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-10-25

5.  Computational Development of Inhibitors of Plasmid-Borne Bacterial Dihydrofolate Reductase.

Authors:  Pedro J Silva
Journal:  Antibiotics (Basel)       Date:  2022-06-07

6.  Crystal structure of a type II dihydrofolate reductase catalytic ternary complex.

Authors:  Joseph M Krahn; Michael R Jackson; Eugene F DeRose; Elizabeth E Howell; Robert E London
Journal:  Biochemistry       Date:  2007-12-04       Impact factor: 3.162

7.  The Bacterial Genomic Context of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases Highlights an Emerging Threat to Public Health.

Authors:  Claudèle Lemay-St-Denis; Sarah-Slim Diwan; Joelle N Pelletier
Journal:  Antibiotics (Basel)       Date:  2021-04-13

8.  Directed evolution strategies for improved enzymatic performance.

Authors:  Edward G Hibbert; Paul A Dalby
Journal:  Microb Cell Fact       Date:  2005-10-07       Impact factor: 5.328

9.  Small Angle Neutron Scattering Studies of R67 Dihydrofolate Reductase, a Tetrameric Protein with Intrinsically Disordered N-Termini.

Authors:  Purva P Bhojane; Michael R Duff; Khushboo Bafna; Pratul Agarwal; Christopher Stanley; Elizabeth E Howell
Journal:  Biochemistry       Date:  2017-11-07       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.